|
1
|
Sung JJ, Lau JY, Goh KL and Leung WK; Asia
Pacific Working Group on Colorectal Cancer: Increasing incidence of
colorectal cancer in Asia: Implications for screening. Lancet
Oncol. 6:871–876. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Thomson S, Petti F, Sujka-Kwok I, Mercado
P, Bean J, Monaghan M, Seymour SL, Argast GM, Epstein DM and Haley
JD: A systems view of epithelial-mesenchymal transition signaling
states. Clin Exp Metastasis. 28:137–155. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Rosivatz E, Becker I, Specht K, Fricke E,
Luber B, Busch R, Höfler H and Becker KF: Differential expression
of the epithelial-mesenchymal transition regulators snail, SIP1,
and twist in gastric cancer. Am J Pathol. 161:1881–1891. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Martin TA, Goyal A, Watkins G and Jiang
WG: Expression of the transcription factors snail, slug, and twist
and their clinical significance in human breast cancer. Ann Surg
Oncol. 12:488–496. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yuen HF, Chua CW, Chan YP, Wong YC, Wang X
and Chan KW: Significance of TWIST and E-cadherin expression in the
metastatic progression of prostatic cancer. Histopathology.
50:648–658. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Arias AM: Epithelial mesenchymal
interactions in cancer and development. Cell. 105:425–431. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Thiery JP: Epithelial-mesenchymal
transitions in tumour progression. Nat Rev Cancer. 2:442–454. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kalluri R and Weinberg RA: The basics of
epithelial-mesenchymal transition. J Clin Invest. 119:1420–1428.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Gheldof A and Berx G: Cadherins and
epithelial-to-mesenchymal transition. Prog Mol Biol Transl Sci.
116:317–336. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Peinado H, Olmeda D and Cano A: Snail, Zeb
and bHLH factors in tumour progression: An alliance against the
epithelial phenotype? Nat Rev Cancer. 7:415–428. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Celesti G, Di Caro G, Bianchi P, Grizzi F,
Basso G, Marchesi F, Doni A, Marra G, Roncalli M, Mantovani A, et
al: Presence of Twist1-positive neoplastic cells in the stroma of
chromosome-unstable colorectal tumors. Gastroenterology.
145:647–657.e15. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Toiyama Y, Yasuda H, Saigusa S, Tanaka K,
Inoue Y, Goel A and Kusunoki M: Increased expression of Slug and
Vimentin as novel predictive biomarkers for lymph node metastasis
and poor prognosis in colorectal cancer. Carcinogenesis.
34:2548–2557. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Guzman JR, Koo JS, Goldsmith JR, Mühlbauer
M, Narula A and Jobin C: Oxymatrine prevents NF-κB nuclear
translocation and ameliorates acute intestinal inflammation. Sci
Rep. 3:16292013. View Article : Google Scholar
|
|
15
|
Chen XS, Wang GJ, Cai X, Yu HY and Hu YP:
Inhibition of hepatitis B virus by oxymatrine in vivo. World J
Gastroenterol. 7:49–52. 2001. View Article : Google Scholar
|
|
16
|
Chai NL, Fu Q, Shi H, Cai CH, Wan J, Xu SP
and Wu BY: Oxymatrine liposome attenuates hepatic fibrosis via
targeting hepatic stellate cells. World J Gastroenterol.
18:4199–4206. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li XM and Brown L: Efficacy and mechanisms
of action of traditional Chinese medicines for treating asthma and
allergy. In: J Allergy Clin Immunol. 123. pp. 297–306; quiz
307–308. 2009
|
|
18
|
Liu H, Sun Y, Gao Y, Chen F, Xu M and Liu
Z: The analgesic effect and mechanism of the combination of sodium
ferulate and oxymatrine. Neurochem Res. 35:1368–1375. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Song G, Luo Q, Qin J, Wang L, Shi Y and
Sun C: Effects of oxymatrine on proliferation and apoptosis in
human hepatoma cells. Colloids Surf B Biointerfaces. 48:1–5. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang Y, Liu H, Jin J, Zhu X, Lu L and
Jiang H: The role of endogenous reactive oxygen species in
oxymatrine-induced caspase-3-dependent apoptosis in human melanoma
A375 cells. Anticancer Drugs. 21:494–501. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ling Q, Xu X, Wei X, Wang W, Zhou B, Wang
B and Zheng S: Oxymatrine induces human pancreatic cancer PANC-1
cells apoptosis via regulating expression of Bcl-2 and IAP
families, and releasing of cytochrome c. J Exp Clin Cancer Res.
30:662011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Song MQ, Zhu JS, Chen JL, Wang L, Da W,
Zhu L and Zhang WP: Synergistic effect of oxymatrine and
angiogenesis inhibitor NM-3 on modulating apoptosis in human
gastric cancer cells. World J Gastroenterol. 13:1788–1793. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang Y, Piao B, Zhang Y, Hua B, Hou W, Xu
W, Qi X, Zhu X, Pei Y and Lin H: Oxymatrine diminishes the side
population and inhibits the expression of β-catenin in MCF-7 breast
cancer cells. Med Oncol. 28(Suppl 1): S99–S107. 2011. View Article : Google Scholar
|
|
24
|
Chen H, Zhang J, Luo J, Lai F, Wang Z,
Tong H, Lu D, Bu H, Zhang R and Lin S: Antiangiogenic effects of
oxymatrine on pancreatic cancer by inhibition of the NF-κB-mediated
VEGF signaling pathway. Oncol Rep. 30:589–595. 2013.PubMed/NCBI
|
|
25
|
Wen JB, Zhu FQ, Chen WG, Jiang LP, Chen J,
Hu ZP, Huang YJ, Zhou ZW, Wang GL, Lin H, et al: Oxymatrine
improves intestinal epithelial barrier function involving
NF-κB-mediated signaling pathway in CCl4-induced cirrhotic rats.
PLoS One. 9:e1060822014. View Article : Google Scholar
|
|
26
|
Iwatsuki M, Mimori K, Yokobori T, Ishi H,
Beppu T, Nakamori S, Baba H and Mori M: Epithelial-mesenchymal
transition in cancer development and its clinical significance.
Cancer Sci. 101:293–299. 2010. View Article : Google Scholar
|
|
27
|
Cano A, Pérez-Moreno MA, Rodrigo I,
Locascio A, Blanco MJ, del Barrio MG, Portillo F and Nieto MA: The
transcription factor snail controls epithelial-mesenchymal
transitions by repressing E-cadherin expression. Nat Cell Biol.
2:76–83. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Baldwin AS: Control of oncogenesis and
cancer therapy resistance by the transcription factor NF-kappaB. J
Clin Invest. 107:241–246. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hayden MS and Ghosh S: Shared principles
in NF-kappaB signaling. Cell. 132:344–362. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Dolcet X, Llobet D, Pallares J and
Matias-Guiu X: NF-kB in development and progression of human
cancer. Virchows Arch. 446:475–482. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wu Y and Zhou BP: TNF-α/NF-kappaB/Snail
pathway in cancer cell migration and invasion. Br J Cancer.
102:639–644. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li CW, Xia W, Huo L, Lim SO, Wu Y, Hsu JL,
Chao CH, Yamaguchi H, Yang NK, Ding Q, et al:
Epithelial-mesenchymal transition induced by TNF-α requires
NF-κB-mediated transcriptional upregulation of Twist1. Cancer Res.
72:1290–1300. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang S, Liu Z, Wang L and Zhang X:
NF-kappaB signaling pathway, inflammation and colorectal cancer.
Cell Mol Immunol. 6:327–334. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Okajima M, Kokura S, Ishikawa T, Mizushima
K, Tsuchiya R, Matsuyama T, Adachi S, Okayama T, Sakamoto N, Kamada
K, et al: Anoxia/reoxygenation induces epithelial-mesenchymal
transition in human colon cancer cell lines. Oncol Rep.
29:2311–2317. 2013.PubMed/NCBI
|
